We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Union Pacific
UNP
$183B
| $231K | ﹤0.01% |
1,720
-2,341
| -58% | -$282K |
|
877
DXP Enterprises
DXPE
$2.62B
| $229K | ﹤0.01% |
+7,742
| New | +$225K |
|
878
Foster
FSTR
$443M
| $229K | ﹤0.01% |
8,425
-1,080
| -11% | -$26K |
|
879
Wintrust Financial
WTFC
$10.7B
| $229K | ﹤0.01% |
2,780
| – | – |
|
880
First Community Bankshares
FCBC
$915M
| $228K | ﹤0.01% |
+7,947
| New | +$234K |
|
|
PRTK
881
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $228K | ﹤0.01% |
+12,730
| New | +$266K |
|
|
PFNX
882
DELISTED
Pfenex Inc.
PFNX
| $227K | ﹤0.01% |
85,332
+31,589
| +59% | +$87.5K |
|
|
BKS
883
DELISTED
Barnes & Noble
BKS
| $227K | ﹤0.01% |
+33,900
| New | +$240K |
|
884
Photronics
PLAB
$1.79B
| $225K | ﹤0.01% |
26,400
| – | – |
|
|
OSG
885
DELISTED
Overseas Shipholding Group Inc.
OSG
| $224K | ﹤0.01% |
81,848
+27,600
| +51% | +$71.8K |
|
886
AutoZone
AZO
$48.3B
| $223K | ﹤0.01% |
314
-15,551
| -98% | -$9.94M |
|
887
United Fire Group
UFCS
$1.32B
| $223K | ﹤0.01% |
4,890
+28
| +0.6% | +$1.31K |
|
888
Enphase Energy
ENPH
$4.84B
| $221K | ﹤0.01% |
91,575
+69,981
| +324% | +$147K |
|
889
Aviat Networks
AVNW
$262M
| $220K | ﹤0.01% |
29,014
+5,400
| +23% | +$42.4K |
|
890
Zevra Therapeutics
ZVRA
$563M
| $219K | ﹤0.01% |
3,374
-75
| -2% | -$4.52K |
|
891
Eversource Energy
ES
$28.2B
| $218K | ﹤0.01% |
3,450
| – | – |
|
|
MBFI
892
DELISTED
MB Financial Corp
MBFI
| $214K | ﹤0.01% |
+4,800
| New | +$217K |
|
893
Monster Beverage
MNST
$91.4B
| $213K | ﹤0.01% |
6,740
-3,000
| -31% | -$89.9K |
|
|
TST
894
DELISTED
TheStreet, Inc.
TST
| $213K | ﹤0.01% |
14,682
-909
| -6% | -$11.1K |
|
|
BFYT
895
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $212K | ﹤0.01% |
8,500
-12,623
| -60% | -$282K |
|
896
American Water Works
AWK
$26.3B
| $211K | ﹤0.01% |
2,310
-32,540
| -93% | -$2.88M |
|
897
Ezcorp Inc
EZPW
$1.82B
| $209K | ﹤0.01% |
17,100
-11,100
| -39% | -$121K |
|
898
Incyte
INCY
$23.5B
| $209K | ﹤0.01% |
2,210
| – | – |
|
|
RYZ
899
Ryerson Holding Corp
RYZ
$1.6B
| $209K | ﹤0.01% |
20,056
+1,629
| +9% | +$15.2K |
|
|
MACK
900
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $209K | ﹤0.01% |
25,928
+8,642
| +50% | +$80.6K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.